Professional Documents
Culture Documents
Healthcare
Drug Supply Chain Disaster: FoxMeyer
● In 1995, FoxMeyer Drugs was the 2nd largest wholesale pharmaceuticals distributor in
the United States with over $5 billion in revenue.
● Poorly written software combined with lack of transparency led to complete disaster
with $34 million of inventory being lost.
● FoxMeyer filed for bankruptcy in 1996 and was sold to its main competitor McKesson
for a measly $80 million.
● About 100,000 deaths a year are linked to the counterfeit drug trade in Africa alone.
● Counterfeiting occurs when a member of the supply chain siphons legitimate drugs and resells them
or enters counterfeit drugs into the supply chain as ‘authentic’ units.
● Counterfeiting can occur at any point in the manufacturing and distribution process and therefore
end-to-end visibility is required.
● There’s limited visibility for the end user or retailer which prohibits better purchasing and
sourcing.
● Hospitals may unknowingly supply patients with counterfeit drugs as they have no way
to verify.
● Blockchains can provide a shared industry-wide logistics platform for all stakeholders.
● The platform would track drugs using blockchains from manufacturing to the end user.
● The platform would help with identification of counterfeit drug and if needed, organize recall.
● The stakeholder would be able to access the sourcing information, authenticate items and ensure
compliance